Hypertonic saline, mannitol and hydroxyethyl starch preconditioning of platelets obtained from septic patients attenuates CD40 ligand expression in vitro

Journal of Trauma - Injury, Infection and Critical Care

Volumn 68, Issue 2, 2010, Pages 331-336

  Huang, Go Shine ^a   Shih, Chien Ming ^b   Wu, Chin Chen ^b   Hu, Mei Hua ^c   Tsai, Chien Sung ^a   Liaw, Wen Jinn ^a   Chan, Shun Ming ^a   Li, Chi Yuan ^d  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CD40L; Hydroxyethyl starch; Hypertonic saline; Mannitol; Platelet; Sepsis

Indexed keywords

CD40 LIGAND; FLUOROCHROME; HETASTARCH; MANNITOL; RINGER SOLUTION; SODIUM CHLORIDE; THROMBIN; THROMBOCYTE ANTIBODY;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DILUTION; FLOW CYTOMETRY; FLUOROCHROME STAINING; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESUSCITATION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE RICH PLASMA;

BLOOD PLATELETS; CD40 LIGAND; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HEMODILUTION; HETASTARCH; HUMANS; MANNITOL; SALINE SOLUTION, HYPERTONIC; SEPSIS;

EID: 77249100883     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181a6028e     Document Type: Article

References (36)

1. Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med. 2002;30(Suppl 5):S313-S317.
2. Heffner JE. Platelet-neutrophil interactions in sepsisp-latelet guilt by association? Intensive Care Med. 1997;23:366-368.
3. Freedman JE. CD40-CD40L and platelet function: beyond hemostasis. Circ Res. 2003;92:944-946.
4. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391: 591-594.
5. Danese S, Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Crit Rev Immunol. 2005;25:103-121.
6. Schonbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci. 2001;58:4-43.
7. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res. 2003;92:1041-1048.
8. Inwald DP, Faust SN, Lister P, et al. Platelet and soluble CD40L in meningococcal sepsis. Intensive Care Med. 2006;32:1432-1437.
9. Schwulst SJ, Grayson MH, DiPasco PJ, et al. Agonistic monoclonal antibody against CD40 receptor decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol. 2006;177:557-565.
10. Nolan A, Weiden MD, Hoshino Y, Gold JA. Cd40 but not CD154 knockout mice have reduced inflammatory response in polymicrobial sepsis: a potential role for Escherichia coli heat shock protein 70 in CD40-mediated inflammation in vivo. Shock. 2004;22:538-542.
11. Nolan A, Weiden M, Kelly A, et al. CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis. Am J Respir Crit Care Med. 2007;177:301-308.
12. Maciel F, Mook M, Zhang H, Vincent JL. Comparison of hypertonic with isotonic saline hydroxyethyl starch solution on oxygen extraction capabilities during endotoxic shock. Shock. 1998;9:33-39.
13. Hannemann L, Reinhart K, Korell R, Spies C, Bredle DL. Hypertonic saline in stabilized hyperdynamic sepsis. Shock. 1996;5:130-134.
14. Wilder DM, Reid TJ, Bakaltcheva IB. Hypertonic resuscitation and blood coagulation: in vitro comparison of several hypertonic solutions for their action on platelets and plasma coagulation. Thromb Res. 2002;107:255-261.
15. Reed RL II, Johnston TD, Chen Y, Fischer RP. Hypertonic saline alters plasma clotting times and platelet aggregation. J Trauma. 1991;31:8-14.
16. Oliveira RP, Velasco I, Soriano F, Friedman G. Clinical review: hypertonic saline resuscitation in sepsis. Crit Care. 2002;6:418-423.
17. Burg MB, Ferraris JD, Dmitrieva NI. Cellular response to hyperosmotic stresses. Physiol Rev. 2007;87:1441-1474.
18. Juttner B, Kuse ER, Elsner HA, et al. Differential platelet receptor expression following hydroxyethyl starch infusion in thrombocytopaenic orthotopic liver transplantation recipients. Eur J Anaesthesiol. 2004;21: 309-313.
19. Franz A, Braunlich P, Gamsjager T, Felfernig M, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg. 2001;92:1402-1407.
20. Stogermuller B, Stark J, Willschke H, Felfernig M, Hoerauf K, Kozek-Langenecker SA. The effect of hydroxyethyl starch 200 kD on platelet function. Anesth Analg. 2000;91:823-827.
21. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
22. Huang GS, Li CY, Hsu PC, Tsai CS, Lin TC, Wong CS. Sevoflurane anesthesia attenuates adenosine diphosphate-induced P-selectin expression and platelet-leukocyte conjugate formation. Anesth Analg. 2004;99: 1121-1126.
23. Gende OA. Hypertonic saline solutions attenuate agonist-induced changes of intracellular calcium. Platelets. 2004;15:23-28.
24. Nesbitt WS, Giuliano S, Kulkarni S, Dopheide SM, Harper IS, Jackson SP. Intercellular calcium communication regulates platelet aggregation and thrombus growth. J Cell Biol. 2003;160:1151-1161.
25. Garrido Adel P, Cruz Junior RJ, Poli de Figueiredo LF, Rocha e Silva M. Small volume of hypertonic saline as the initial fluid replacement in experimental hypodynamic sepsis. Crit Care. 2006;10:R62.
26. Kolsen-Petersen JA. Immune effect of hypertonic saline: fact or fiction? Acta Anaesthesiol Scand. 2004;48:667-678.
27. Thaler U, Deusch E, Kozek-Langenecker SA. In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions. Anaesthesia. 2005;60:554-559.
28. Gende OA. Effect of hyperosmolarity on agonist-induced increases of intracellular calcium in human platelets. Thromb Res. 2003;110:33-37.
29. Gamsjager T, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches on intracellular calcium in platelets. Anesth Analg. 2002;95:866-869.
30. Deusch E, Thaler U, Kozek-Langenecker SA. The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesth Analg. 2004;99:665-668.
31. Adelson PD, Bratton SL, Carney NA, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 4. Resuscitation of blood pressure and oxygenation and prehospital brain-specific therapies for the severe pediatric traumatic brain injury patient. Pediatr Crit Care Med. 2003; 4(Suppl 3):S12-S18.
32. Doyle JA, Davis DP, Hoyt DB. The use of hypertonic saline in the treatment of traumatic brain injury. J Trauma. 2001;50:367-383.
33. Knapp JM. Hyperosmolar therapy in the treatment of severe head injury in children: mannitol and hypertonic saline. AACN Clin Issues. 2005; 16:199-211.
34. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-139.
35. Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol. 1998;161: 6288-6296.
36. Bhatt DL, Topol EJ. Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov. 2003;2:15-28.